Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Swiss-listed BB Biotech marks 30 years of outperformance with fund manager Dr. Daniel Koller confident the recent biotechnology slump will in time look like a small setback.

This crash will look like a blip

Swiss-listed BB Biotech marks 30 years of outperformance with fund manager Dr. Daniel Koller confident the recent biotechnology slump will in time look like a small setback.
05.12.2023 - Daniel Koller

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993